Neil Kumar

CIK 1742485 · Chief Executive Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.06M

Companies

2

Total Filings

79

Lifetime Open-Market Net

-$73.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBIO Chief Executive Officer 4,581,774 $66.80 $306.06M -$145.07M 76 2026-06-08
Eidos Therapeutics, Inc. (EIDX) Delisted Chief Executive Officer 24,575,501 $72.01M 3 2019-07-08

Recent Filings · Page 7 of 8

79 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-08-18 BBIO Mixed +3,355 -$50.6K EDGAR
2020-08-05 BBIO Sell (S) −80,000 -$2.18M EDGAR
2020-07-06 BBIO Sell (S) −143,470 -$4.41M EDGAR
2020-06-10 BBIO Sell (S) −10,600 -$318.1K EDGAR
2020-06-05 BBIO Mixed −5,930 -$178.2K EDGAR
2020-06-03 BBIO Sell (S) −80,000 -$2.34M EDGAR
2020-05-06 BBIO Sell (S) −79,600 -$2.47M EDGAR
2020-05-05 BBIO Sell (S) −80,400 -$2.36M EDGAR
2020-04-09 BBIO Sell (S) −1,805 -$46.0K EDGAR
2020-04-06 BBIO Sell (S) −300 -$7.5K EDGAR
Showing 6170 of 79
Page 7 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.